Dedicated to transforming the lives of patients with severe and other genetic diseases through innovative gene therapy.
Stem cell technology • Gene therapy • Orphan diseases • Paediatric diseases
201 - 500
💰 $150M Post-IPO Equity on 2021-02
August 17
🔄 Hybrid – London
⏰ Full Time
🟡 Mid-level
🟠 Senior
♟ Business Operations & Strategy
July 24
🔴 Lead
July 11
🔧 QA Engineer (Quality Assurance)
Google Cloud Platform
June 27